Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics.[4]
History
Torrent Pharmaceuticals was established in 1959 by U. N. Mehta as Trinity Laboratories. It was renamed Torrent Pharmaceuticals in 1971.[5]
In 1997, Torrent Pharma and Sanofi established a 50:50 joint venture called Sanofi Torrent for selling Torrent Pharma's products.[6] Torrent exited the joint venture by selling its stake to Sanofi in 2002.[7]
In 2005, Torrent Pharmaceuticals acquired Heumann Pharma Generics GmbH, a Pfizer company based in Germany.[8]
In 2013, Torrent Pharma acquired the India formulations business of Elder Pharmaceuticals for inr 20040000000.[9]
In 2017, Torrent Pharma acquired the domestic business of Unichem Laboratories for inr 36000000000.[10]
In 2022, the company acquired skincare manufacturer Curatio Healthcare for inr 20000000000.[11]
Recalls
In 2018, Torrent Pharmaceuticals recalled tablets containing valsartan[12][13] and losartan[14] due to the detection of N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA) respectively which are probable human carcinogens.
In September 2019, the FDA issued notice of a sixth product recall of losartan by Torrent Pharmaceuticals when certain batches of losartan contained the contaminant, N-methylnitrosobutyric acid (NMBA), above acceptable daily intake levels determined by the FDA.[15]
See also
- Pharmaceutical industry in India
External links
References
- Aman Mehta appointed Managing Director of Torrent Pharma The Economic Times, 20 May 2025^
- Torrent Pharma announces Q4 FY25 results Torrent Pharmaceuticals, retrieved 28 May 2025^
- Results Q4 And Year Ended 31-03-2025 Torrent Pharmaceuticals Limited, retrieved 28 May 2025^
- Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore Medical Dialogues, 23 July 2019^
- Torrent Pharmaceuticals Ltd. Medical Dialogues, 7 September 2022, retrieved 28 May 2024^
- Sanofi Torrent To Sell Torrent Pharma Products Business Standard, 7 April 1997, retrieved 28 May 2024^
- Torrent exits JV with Sanofi-Synthelabo: Reuters Rediff, retrieved 28 May 2024^
- Torrent to buy Pfizer group's Heumann Pharma The Economic Times, 28 June 2005, retrieved 28 May 2024^
- Torrent buys Elder Pharma business for Rs 2,004 crore The Indian Express, 14 December 2013, retrieved 28 May 2024^
- Divya Rajagopal. Torrent Pharma walks away with Unichem's domestic business for Rs 3,600 crore The Economic Times, 8 November 2017, retrieved 28 May 2024^
- Teena Thacker. Torrent Pharmaceuticals to acquire 100% of Curatio Healthcare for Rs 2,000 crores The Economic Times, 27 September 2022, retrieved 28 May 2024^
- Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets Food and Drug Administration, 2018^
- FDA updates on valsartan recalls Food and Drug Administration, 2018^
- Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP Food and Drug Administration, 2018^
- Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium / Hydrochlorothiazide Tablets, USP US Food and Drug Administration, 23 September 2019, retrieved 23 September 2019^